An improved high throughput protein-protein interaction assay for nuclear hormone receptors by Goodson, Michael L. et al.
An improved high throughput protein-protein
interaction assay for nuclear hormone receptors
Michael L. Goodson, Behnom Farboud and Martin L. Privalsky
Corresponding Author: mlprivalsky@ucdavis.edu
Section of Microbiology, Division of Biological Sciences, University of California at Davis, Davis, California, USA
The Glutathione-S-Transferase (GST) “pulldown” assay has been used extensively to assay protein interactions
in vitro.This methodology has been especially useful for investigating the interactions of nuclear hormone
receptors with a wide variety of their interacting partners and coregulatory proteins. Unfortunately, the original
GST-pulldown technique relies on multiple binding, washing and elution steps performed in individual
microfuge tubes, and requires repeated centrifugation, aspiration, and suspension steps.This type of batch
processing creates a significant liquid handling bottleneck, limiting the number of sample points that can be
incorporated into one experiment and producing inherently less efficient washing and elution than would a
flow-through methodology. In this manuscript, we describe the adaptation of this GST-pulldown assay to a
96-well filter plate format.The use of a multi-well filter plate makes it possible to assay more samples in
significantly less time using less reagents and more efficient sample processing than does the traditional
single tube assay.
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Introduction
Nuclear receptors (also known as nuclear hormone
receptors or intracellular receptors) are ligand-regulated
transcription factors that play key roles in metazoan
homeostasis, development, and reproduction [Apriletti et
al., 1998; Beato and Klug, 2000; Chambon, 1996;
Mangelsdorf et al., 1995; Zhang and Lazar, 2000].To
regulate their target genes, nuclear receptors must
participate in an interwoven network of protein-protein
interactions. For example, most nuclear receptors bind
to their DNA recognition sites through a combination of
DNA-protein and protein-protein interactions that generate
receptor dimers; the nature and composition of these
protein dimers define both the target gene specificity and
the transcriptional properties of the participating receptors
[Glass, 1996; Mangelsdorf and Evans, 1995]. Once
assembled on DNA, the receptor dimers then must recruit
additional auxiliary polypeptides, denoted corepressors
and coactivators, to modulate expression of their target
genes [Glass and Rosenfeld, 2000; Lazar, 2003; Lee et
al., 2001; Leo and Chen, 2000; McKenna and O'Malley,
2002; Ordentlich et al., 2001; Xu and Li, 2003].
Corepressors and coactivators themselves assemble into
multiple protein complexes to exert their functions, which
can include further interactions with chromatin proteins
and with components of the general transcriptional
machinery. All levels of nuclear receptor function are
subject to regulation by post-translational modifiers, such
as kinases and allosteric modulators, which recognize
their substrates through still additional protein-protein
interactions (e.g. [Rochette-Egly, 2003; Stallcup et al.,
2003;Weigel, 1996]).
A variety of methodologies have been applied to dissect
this web of protein-protein interactions. One of the most
broadly useful techniques has been a "pull-down"
approach by which an immobilized "bait" protein is
assayed for the ability to bind to and retain a second
"prey" protein after incubation in vitro.The most common
version of this approach uses a glutathione-S-transferase
(GST) bait protein fusion, expressed in bacteria and
immobilized on glutathione-agarose, together with a
radiolabeled prey protein synthesized by in vitro
transcription and translation; after co-incubation, washing,
and elution, the recovered bait and prey proteins can be
analyzed by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and quantified by
autoradiography or phosphorimager analysis [Guan and
Dixon, 1991].This basic protocol can also be modified in
a variety of ways. For example, other fusion tags, such
as six-histidines or the maltose binding protein, can be
used in place of GST to immobilize the bait protein to a
corresponding insoluble matrix (e.g. [Bedouelle and
Duplay, 1988; Chen and Hai, 1994; di Guan et al., 1988;
Janknecht et al., 1991; Maina et al., 1988]). Bait protein
fusions can be expressed in yeast, in baculovirus-infected
insect cells, or in mammalian cell expression systems
rather than in bacteria.The prey protein need not be
radioactive, but alternatively can be detected by
immunoblot, enzyme assay or ELISA methodologies.
Despite their general utility, standard GST-pulldown
assays are performed in individual microcentrifuge tubes
and require considerable sample handling involving
repeated mixing, centrifugation, aspiration, and
resuspension of each sample.This batch
collection/resuspension approach reduces the efficiency
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can be expediently analyzed in any one experiment to
the capacity of a microcentrifuge rotor, and introduces a
considerable time delay that can interfere with detection
of unstable protein-protein interactions.We describe here
a modification of the GST-protocol to a 96-well filter plate
format that substantially simplifies the technique, saves
in reagent costs and investigator time, and enhances the
efficiency of the process.This modification permits
multiple protein-protein interaction assays to be rapidly
and reproducibly performed in parallel, simplifying the
generation of apparent affinity curves and the
determination of the effects of modifiers and reagent
conditions.This general methodology should also be
readily adaptable to a variety of bait protein tags, prey
protein detection techniques, and automation systems.
Reagents and instruments
COMPLETE protease inhibitor,
(Boehringer-Mannheim/Roche, Indianapolis, IN);
Glutathione-agarose, (Sigma Chemical Company, Saint
Louis, MO);TNT T7 Quick Coupled
Transcription/Translation System, (Promega, Madison,
WI); 96-well MultiScreen-HV plate, (Millipore, Billerica,
MA); 96 V-well polystyrene plate, (Corning, Acton, MA);
TemPlate adhesive film, (USA Scientific, Ocala, FL);
Branson sonifier 250, (Branson Corporation, Danbury,
CT); 840 Phosphorimager Storm System, (Molecular
Dynamics, Sunnyvale, CA); ImageQuant software,
(Amersham Biosciences, Piscataway, NJ); Roto-Shake
Genie, (Scientific Industries, Bohemia, NY); IEC Centra
MP4 centrifuge with microplate rotor, (Thermo Electron,
Waltham, MA); Reacti-Bind glutathione-coated plate,
(Pierce Biotechnology, Rockford, IL)
Methods
Plasmids
A variety of GEX bacterial vectors have been described
that can express a glutathione-S-transferase (GST) fusion
of the bait protein of interest; for the experiments
described here, we used pGEX-KG vectors to synthesize
non-recombinant GST (employed as a negative control),
a GST-SMRT corepressor fusion (encoding amino acids
2077-2471 of SMRTτ) or a GST-ACTR coactivator fusion
(encoding amino acids 621-821of ACTR) [Chen et al.,
1997; Goodson et al., 2005]. Similarly, a variety of vectors
containing T7 or analogous phage promoters can be
employed for the synthesis of radiolabeled prey protein
in vitro; pSG5 vectors encoding full length retinoic acid
receptor (RAR)α, thyroid hormone receptor (TR)α, or
farnesoid X receptor (FXR) were employed here [Chan
and Privalsky, 2006; Farboud and Privalsky, 2004;
Forman et al., 1995].
Standard GST-pulldown assay
The glutathione-S-transferase (GST) fusion proteins are
expressed in Escherichia coli (BL-21-strain) transformed
by the corresponding pGEX vectors [Guan and Dixon,
1991]. Overnight cultures are inoculated 1:100 into LB
broth (50 to 1000 ml) containing 100 µg/ml ampicillin and
are grown with vigorous aeration at 37°C to an O. D. 600
nm = 0.8. Expression of the GST-fusion protein is induced
by addition of 1 mM isopropylthiogalactopyranoside
(IPTG) and the cultures are maintained at 37°C for an
additional 3 hr. prior to harvesting by centrifugation at
4000 x g for 15 min.; this protocol was followed for the
GST and GST-ACTR constructs described here. For
some protein fusions (such as the GST-SMRT construct),
greater solubility is achieved if the cultures are induced
by IPTG addition and maintained at 16°C for 16 hr. prior
to harvesting by centrifugation.
All subsequent steps are either on ice or at 4°C.The
bacteria are washed twice in phosphate-buffered saline
(PBS), resuspended in 5 ml of PBS containing
COMPLETE protease inhibitor (Boehringer-Mannheim
/Roche, Indianapolis, IN), and are lysed by three 30 sec
bursts in a Branson sonicator with 1/2 inch horn at the
#9 setting.The lysates are then clarified by a 20 min.
centrifugation at 30,000 x g and either used immediately,
or quick frozen as aliquots and stored at −80°C for future
use. Glutathione-agarose (Sigma Chemical Company,
Saint Louis, MO) is prepared by swelling for 10 min. in
PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.45
mM KH2PO4), then collected by a 30 sec. centrifugation
at 1,000 x g, washed twice in 20 volumes each of PBS,
and suspended as a 50% slurry in PBS. For each binding
reaction 50 µl of washed glutathione agarose slurry is
mixed with the desired amount of bacterial lysate
(containing from 50 to 1000 ng of immobilized GST fusion
protein) in 500 µl of PBS + COMPLETE protease inhibitor
+ 1mM DTT. After a 1 hr. incubation on a rocker platform
at 4°C, the GST-fusion bait protein, now immobilized on
the glutathione-agarose, is recovered by a 30 sec.
centrifugation at 1,000 x g, washed twice with PBS
containing 0.5% Triton X-100 and 1mM DTT, and
resuspended as a 50% slurry in Buffer A (25mM HEPES,
pH 7.8; 50mM KCl; 5mM EDTA; 5mM MgCl2; 0.5% Triton
X-100; 6% glycerol; 1mM dithiothreitol) for binding to the
radiolabeled prey protein, below.
35S-radiolabeled proteins are prepared in vitro by use of
a phage RNA polymerase-coupled
transcription/translation kit following the manufacturer’s
recommendations (e.g.TNT T7 Quick Coupled
Transcription/Translation System, Promega, Madison,
WI). For the traditional tube-based assay, the 
35S-labeled
proteins are transferred into 1.5 ml microfuge tubes, 500
µl of Buffer A containing COMPLETE proteinase inhibitor,
and 5 mg/ml of bovine serum albumin are added, and the
incubation is begun by addition of 50 µl/per tube of a 50%
slurry of the appropriate immobilized GST fusion protein.
The bovine serum albumin can be omitted in experiments
utilizing hormones that may be adsorbed by this protein
carrier.The microfuge tubes are capped and incubated
on a rocker platform for 30 min. at 4°C.The immobilized
GST-protein, and any prey protein bound to it, are then
recovered by a 10 sec. centrifugation (1,000 x g).The
supernatants are aspirated, the agarose matrix is
resuspended in 1 ml/tube of PBS containing 0.5% Triton
X-100 and 1mM DTT by a 5 sec. inversion mixing, and
the centrifugation step is repeated.The wash steps are
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glutathione-agarose matrix are eluted by incubation for
30 min. at 4°C in 50 µl/tube of 20 mM free glutathione in
100 mM Tris-Cl pH 8.0.The matrix is pelleted by a final
centrifugation and the eluated proteins are resolved by
SDS-PAGE and visualized/quantified by phosphorimager
analysis (Molecular Dynamics Storm System, Sunnyvale,
CA).
Figure 1. Comparison of GST-pulldown methodologies: microfuge
tube versus filter-plate protocols. Non-recombinant GST, GST-SMRTτ
(amino acids 2077-2471; A, C, E and F), or GST-ACTR (amino acids
621-821; B, D, and F) bound to glutathione agarose were incubated with
in vitro translated 
35S-methionine radiolabeled TRα1 (A, B and F), RARα
(C and D), or FXR (E) protein in either the absence (open bars) or
presence (filled bars) of cognate agonist (1 µM T3 for TRα1, 1µM ATRA
for RARα or 100 µM CDCA for FXR). Samples were bound, washed, and
eluted with free reduced glutathione using the conventional individual
tube assay (“Single Tube”), the modified filter microplate assay (“Filter
Plate”), or the glutathione coated Reacti-Bind plate assay (“Coated Plate”).
Extended wash filter microplate samples (“Extnd.Wash”) were incubated
15 min between washes. Samples were resolved on a SDS-10% PAGE
gel prior to fixing, staining and scanning of the dried gel with a Molecular
Dynamics Storm 840 Phosphorimager. Quantification of the radiolabeled
bands was performed using ImageQuant software version 4.2. Assays
were performed in triplicate; error bars indicate standard deviation. (F)
Representative Phosphorimager gel images used for analysis in panels
A and B.
Improved 96 well filter plate format
The immobilized GST-fusion bait proteins and
radiolabeled prey proteins are prepared as for the
standard procedure, above. Four to five µl of glutathione
agarose (containing from 50 to 1000 ng of immobilized
GST fusion protein) plus 100 µl of Buffer A (containing 5
mg/ml bovine serum albumin and COMPLETE protease
inhibitor) are aliquoted per well of a MultiScreen-HV plate
(Millipore Billerica, MA). Aliquots of the in vitro translated
prey protein (4 µl unless otherwise stated) representing
4 x 10
5 to 4 x 10
6 dpm 
35S radiolabel are added per well,
the filter plate is placed on top of an empty 96-well
polystyrene plate (Corning, Acton, MA), and the top filter
plate is sealed with TemPlate adhesive film (USA
Scientific, Ocala, FL). Although not required, we also
typically heat-seal the dual plate sandwich in a
polyethylene bag to provide redundant radiological
containment.The prey and GST-bait are then incubated
together on an inverting platform at 5 to 8 rpm for 30 min.
at 4°C; we typically use magnetic strips to attach the bag
and plate sandwich to a rotating metal platform such as
the Roto-Shake Genie (Scientific Industries, Bohemia,
NY) or similar apparatus.The plates are subsequently
unsealed and the prey proteins not bound to the
GST-fusion are removed by a 1,000 x g centrifugation for
60 seconds at 25°C in an IEC Centra MP4 centrifuge with
a microplate rotor (Thermo Electron, Waltham, MA).
Plates are then washed three times by adding 200 µl of
PBS containing 0.5% Triton X-100 and 1mM DTT per
well with a multi-channel pipetter and centrifuging as
above. Bound proteins are eluted by placing the filter
plate on top of a fresh 96 well V-bottom plate, adding 50
µl of elution buffer (20 mM glutathione, 100 mM Tris-HCl
pH 8.0) to each well, sealing the plate sandwich as before,
and incubating it for an additional 30 min. at 4°C with
continuous rotation. Protein complexes eluted by the 20
mM glutathione are then collected by centrifuging the
samples into the 96-well bottom plate, and are prepared
for electrophoresis by adding 20 µl of 4x SDS-PAGE
sample buffer (125 mM Tris-HCl, pH 6.8, 20% Glycerol,
4% SDS, 1.4 M ß-mercaptoethanol, 0.5 mg/ml
bromophenol blue) to each well.The samples are heated
at 95°C on a dry block for 5 min. and analyzed by
SDS-PAGE.The recovery of GST-bait proteins can be
visualized by Coomassie blue staining and the recovery
of prey proteins can be determined and quantified by
phosphorimager analysis (Storm840 and ImageQuant
software, Amersham Biosciences, Piscataway, NJ).
Surface immobilized plate format
Saturating amounts (equivalent to the amounts used for
the corresponding filter plate assay) of GST or GST-fusion
protein extract were bound to Reacti-Bind glutathione
coated plates (Pierce Biotechnology, Rockford, IL). After
a 30 min. incubation on a rocker platform at 4°C, the
GST-fusion bait proteins, now immobilized on the
glutathione coated plate, are washed twice with PBS
containing 0.5% Triton X-100 and 1mM DTT.The in vitro
translated prey proteins are prepared and bound as
previously described for the filter microplate assay. After
a 30 min. incubation on a rocker platform at 4°C, the prey
proteins not bound to the GST-fusion are removed by
aspiration. Plates are then washed three times by adding
200 µl of PBS containing 0.5% Triton X-100 and 1mM
DTT per well with a multi-channel pipetter and aspirating
as above. Bound proteins are eluted by adding 50 µl of
elution buffer (20 mM glutathione, 100 mM Tris-HCl pH
8.0) to each well, and incubating for an additional 30 min.
at 4°C with continuous agitation. Eluted protein complexes
are removed from the Reacti-bind coated plates and
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assay.
Results
Comparison of the 96-well plate and the
individual tube GST-pulldown assays
We compared the 96-well plate and the individual tube
assay by examining the ability of two different nuclear
receptors, thyroid hormone receptor α (TRα) and retinoic
acid receptor α (RARα), to bind to two coregulatory
proteins, the SMRT corepressor and the ACTR
coactivator.We synthesized the radiolabeled receptors
and GST-coregulators, performed the GST-pulldowns,
and analyzed the eluted proteins by SDS-PAGE/
phosphorimager analysis as described in Materials and
Methods; the average and standard deviation of triplicate
experiments are presented (Figure 1). Nuclear receptors
are known to bind to corepressors in the absence of
hormone agonist, but release from corepressors and bind
coactivators in the presence of hormone agonist.The
results of both methods paralleled these expectations:
both TRα and RARα bound to the GST-SMRT
corepressor construct in the absence of hormone, but
this binding was significantly reduced in the presence of
cognate hormone agonist (T3 or all-trans retinoic acid,
respectively) (Figure 1A and Figure 1C). Reciprocally,
binding of either receptor to the GST-ACTR coactivator
construct was minimal in the absence of hormone, but
was significantly increased in the presence of the cognate
agonist (Figure 1B and Figure 1D). Both tube and plate
based assays were internally reproducible, and both
yielded very low background binding to the GST negative
control construct (Figure 1). Representative
Phosphorimager gel images showing the interaction of
TRα with GST, GST-SMRT and GST-ACTR in the
presence and absence of hormone for both the individual
tube assay and filter microplate assay are presented in
Figure 1F.
Notably, the plate assay was consistently more efficient
than was the tube assay under these conditions,
displaying a higher percent of the input receptor binding
to the GST-SMRT and GST-ACTR constructs than was
observed with the tube-based technique.To determine
if this increased interaction in the microplate was due to
the significantly reduced processing time involved with
the wash steps of the filter microplate assay, we added
a 15 minute incubation to each of the wash steps to
simulate the extended wash times of the individual tube
assays (Figure 1 A, “Extnd.Wash”). Extending the wash
times reduced the efficiency of the filter microplate binding
reaction to nearly that observed for the individual tube
assay. Because of the increased efficiency of the filter
microplate assay, we wanted to determine if this assay
would be suitable for analyzing weaker protein
interactions, such as the interaction between the farnesoid
X receptor (FXR) and the corepressor SMRT (Figure 1E).
In the individual tube assay, the interaction between FXR
and SMRT is only marginally above background; whereas
in the filter microplate interaction, there is a readily
observable interaction (Figure 1E).This interaction is
slightly, but reproducibly, diminished (p<0.05) in the
presence of the FXR ligand, chenodeoxycholic acid
(CDCA) [Makishima et al., 1999; Parks et al., 1999]. As
with TRα, the amount of FXR bound to SMRT in the filter
plate assay is reduced with extended wash times, though
not to the extent of the single tube assay (Figure 1E).
These results suggest that the 96-well filter plate
approach is equal or better in utility to the traditional
individual tube method for high affinity interactions, such
as between TR or RAR and their coregulatory partners.
Unlike the individual tube assay, the filter microplate
assay is also suitable for analyzing lower affinity
interactions, such as between FXR and SMRT or other
cofactors.
Figure 2. Titration of the binding of regulators to nuclear receptors
by the plate or single tube methods. GST-ACTR (amino acids
621-821), either 400 ng (triangles) or 200 ng (diamonds), bound to
glutathione agarose was incubated with increasing amounts of in vitro
translated 
35S-methionine radiolabeled TRα1 (A) or RARα (B) in the
presence of cognate agonist (1 µM T3 for TRα or 1 µM ATRA for RARα).
GST-SMRTτ (amino acids 2077-2471) bound to glutathione agarose was
incubated with increasing amounts of in vitro translated 
35S-methionine
radiolabeled TRα1 (C) in the absence of cognate agonist. Samples were
bound, washed, and eluted with free reduced glutathione in either the
conventional individual tube assay (squares) or the modified filter
microplate assay (triangles) and were analyzed as in Figure 1. Data was
fit to a single-site hyperbolic binding curve using GraphPad Prism v. 4.0.
(D) The Phosphorimager gel images used for analysis in panel C.
A different GST pulldown assay has been described using
a specialized microplate with a glutathione coated surface
to assay antibody-antigen interactions [Murray et al.,
1998].To compare our filter microplate assay to the
coated microplate assay, we incubated identical amounts
of GST-fusion bait protein (approximately 1000 ng) with
glutathione agarose and the Reacti-Bind plate.This
amount of protein was saturating for the coated plates,
which have a reported maximum GST binding capacity
of 10 ng/well (as opposed to 5 µg/µl for the glutathione
agarose resin). Not unexpectedly, only a slight interaction
is observed between TRα and SMRT using the coated
microplates (Figure 1A) and no interaction is observed
between FXR and SMRT (Figure 1E).Thus the lower
binding capacity of the coated microplate appears to
restrict its suitability to only very high affinity interactions.
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assay
GST-pulldown methods are inherently non-equilibrium
systems, and, when used with in vitro transcription/
translation mixtures, contain additional proteins and other
components that can potentially influence the results.
Nonetheless, a useful GST-pulldown assay should mimic
many of the characteristics anticipated from a
Michaelis-Menten description and display well-behaved
saturable binding that adequately reflects the avidity of
one protein for the other.We tested this by repeating the
GST-pulldown filter plate assay using a wide range of
TRα or RARα proteins and two different concentrations
of GST-ACTR construct (Figure 2). As hoped, both
nuclear receptors displayed binding to the
GST-coactivator that fit theoretic expectations for a
two-component protein-protein interaction (Figure 2 and
Table 1).These results confirm that the GST-pulldown
microplate method is well-behaved and is a useful
measure of the protein-protein interaction itself. Similar
experimentally well-behaved interactions are observed
between TRα and SMRT in both the single tube and filter
microplate assays (Figure 2C and Figure 2D), with the
overall interaction being reduced in the individual tube
assays, as before.
Table 1. Regression analysis of plate assay. Best fit values and
standard errors from the non-linear regression analysis of the quantification
of the interaction of GST-ACTR with varying amount of in vitro translated
TRα1 and RARα protein (Figure 2).The data were fit to the equation
Y=Bmax
*X/(Kd+X) with the constraints of Bmax<100 and Kd>0.The
analysis was done using GraphPad Prism v. 4.0.
We next determined if the GST filter plate methodology
could also quantify the effects of hormone ligands on the
interactions of nuclear receptors with their coregulators.
We tested the ability of a range of hormone agonist
concentrations (T3 or all-trans retinoic acid) to induce
binding of TRα or RARα to the GST-ACTR coactivator
(Figure 3).These titrations produced sigmoidal curve fits
fully consistent with prior, tube-based GST-pulldown
assays (Figure 3). Reciprocal results were observed when
testing the hormone-induced release of these receptors
from the GST-SMRT corepressor construct (data not
shown).We conclude that the GST-pulldown filter plate
method is sufficient to allow a quantitative analysis of
these phenomena.
Comparison of centrifugation verses vacuum
manifold washing methods
The assays detailed above employed a tabletop centrifuge
equipped with microplate holders to expel each wash into
a collecting tray. Our setup permits up to four 96-well filter
plates (384 samples) to be analyzed in parallel; other
centrifuges and configurations potentially further double
these quantities. Alternatively, any of a number of
commercially-available or custom-constructed manifolds
can be employed to wash the plate wells under vacuum.
We therefore compared these two wash methods in
parallel, testing the ability of TRα to bind to GST-SMRT
corepressor in the absence or presence of T3 hormone
(Figure 4). Notably, the filter plate centrifugation and filter
plate vacuum manifold assays yielded virtually
indistinguishable results in terms of background, binding
efficiency, and reproducibility.These results further extend
the general applicability of this microplate methodology.
Figure 3. Analysis of the effects of hormone agonists on the
receptor/coactivator interaction using the plate method. GST-ACTR
(amino acids 621-821) bound to glutathione agarose was incubated with
in vitro translated 
35S-methionine radiolabeled TRα1 (A) or RARα (B)
protein in presence of increasing amounts of cognate agonist. Samples
were analyzed using the filter plate method as in Figure 1. Data was fit
to a sigmoidal dose response curve with variable slope using GraphPad
Prism v. 4.0.
Comparison of SDS-PAGE analysis versus
scintillation counting for quantification
Typically, prey proteins bound and eluted from the
GST-bait are then analyzed by SDS-PAGE.This permits
a specific prey protein of interest to be resolved and
quantified independent of any other radiolabeled
translation product, and also allows the integrity and
quantity of the GST-bait proteins to be determined by
Coomassie blue staining of the same electrophoretogram
as that used for the radioactive quantification. Notably,
however, the in vitro transcription/translation system often
produces a relatively pure radiolabeled prey protein with
virtually no other detectable translation products; under
this circumstance, SDS-PAGE analysis after the
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concept by analyzing the interaction of TRα with
GST-SMRT using the 96-well filter plate assay, but
quantifying each sample either by
SDS-PAGE/phosphorimager analysis, or by subjecting
the entire protein eluate to aqueous liquid scintillation
counting in the absence of any further fractionation
(Figure 5). No significant differences were detected
between these analyses (Figure 5).We conclude that (a)
when using radiologically homogeneous prey protein
preparations and (b) for sufficiently robust protein-protein
interactions, the filter plate GST-pulldown approach can
be further simplified, and the analysis considerably
accelerated, by direct scintillation analysis of the
radioactive eluates without a subsequent SDS-PAGE
step.
Figure 4. Comparison of centrifuge washing versus vacuum
manifold washing for plate methodology. (A) GST-SMRTτ (amino
acids 2077-2471) bound to glutathione agarose was incubated with in
vitro translated 
35S-methionine radiolabeled TRα1 protein; empty wells,
glutathione agarose alone, or glutathione agarose bound to GST were
used as negative controls as indicated. Samples were washed using
either a centrifuge (open bars) or vacuum manifold (filled bars), eluted
and analyzed as described in Figure 1. (B) GST-ACTR (amino acids
621-821) bound to glutathione agarose was incubated with in vitro
translated 
35S-methionine radiolabeled TRα1 protein in either the absence
or presence of cognate agonist (1 µM T3). Samples were washed using
either a centrifuge (open bars) or vacuum manifold (filled bars), eluted,
and analyzed using the filter plate method as described in Figure 1. Assays
were performed in triplicate; error bars indicate standard deviation.
Discussion
We have adapted the existing GST-pulldown
protein-protein interaction assay, traditionally performed
in individual microfuge tubes, to a high-throughput 96-well
filter plate format. As demonstrated here, the 96-well
format displays low background, good reproducibility, and
strong positive signals, and is comparable or better to the
individual tube method by these criteria.The 96-well
format produces good fits to expected two-component
binding curves in response to varying receptor,
coregulator, or hormone ligand concentrations.The speed
of the filter plate method also favors the detection of
relatively weak or short half-life interactions which may
not be sufficiently stable to detect over the longer time
course required for the single tube methodology.
Figure 5. Comparison of plate assay quantification by
SDS-PAGE/phosphorimager analysis versus analysis by liquid
scintillation counting. Non-recombinant GST or GST-ACTR (amino
acids 621-821) were bound to glutathione agarose, and were incubated
with in vitro translated 
35S-methionine radiolabeled TRα1 or RARα protein
in presence of cognate agonist (1 µM T3 or 1 µM ATRA). Samples were
washed and eluted using the filter plate method as described in Figure
1. After elution, a 20 µl aliquot (out of 70 µl total) of each sample was
resolved on a SDS-10% PAGE gel prior to Coomassie staining and
visualization of the dried gel with a Molecular Dynamics Storm 840
Phosphorimager. A separate 5 µl aliquot of each sample was subjected
to scintillation counting using BioSafe II scintillation cocktail (Research
Products International, Mt. Prospect, IL) and a Beckman LS6500 liquid
scintillation counter (Beckman Coulter, Fullerton, CA). Assays were
performed in triplicate; error bars indicate standard deviation.
The relative ease of analyzing multiple samples in parallel
makes the 96-well filter plate format particularly well suited
to high throughput analysis of large numbers of different
receptors or their coregulators, different mutant
constructs, or for detailed titrations examining the effect
of hormone or receptor concentration on a protein-protein
interaction. Of equal importance: the 96-well modification
of the GST-pulldown method reduces the manual
intervention time required for pipetting during the wash
and elution steps from approximately 6 minutes per wash
(assuming 20 samples) to approximately twenty seconds
per wash (assuming 96 samples); thus the microplate
assay represents a more than 10-fold reduction in
investigator time. Using a simple tabletop centrifuge for
the wash steps, 384 samples or more can readily be
manually analyzed in parallel; alternatively, the same
96-well format can be utilized with a vacuum manifold to
further speed the washing steps, or can be adapted to
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intervention.The micro-plates are readily stacked,
manipulated, and stored, and unlike the traditional tube
method, do not require the additional effort of uniquely
labeling each individual sample tube.
In addition to the reductions in investigator time and effort,
there are also reagent savings. A minimum of 25 µl per
sample of glutathione agarose is needed when using the
individual microfuge tube format to form a visible pellet
and to avoid significant loss of resin during the repeated
manual washing steps; in contrast, the membrane-like
surface of the 96-well filter plates permits as little as 5 µl
of glutathione-agarose to be used per sample.The cost
of the glutathione agarose (and the cost of the protease
inhibitor in the reduced volume of binding buffer used in
the plate method) are therefore approximately 20% of the
cost for the individual tube assay ($0.15/sample versus
$0.75/sample).With the filter microplate assay there is a
fixed cost of approximately $15.00 for each microplate
and seal, resulting in the filter plate method being more
economical for assays representing 25 samples or
greater. Depending on the nature of the interaction, it
may also be possible to further reduce the expense per
assay by reducing the amount of in vitro translated protein
used, although potentially with the risk of reduced
sensitivity (Figure 2).
The 96-well filter plate assay system described here can
also be modified to expand its general applicability. A
variety of different agarose matrices are available that
can be substituted in place of the glutathione-agarose
employed here, permitting a range of bait protein fusion
tags to be employed in the 96-well plate format (e.g.
maltose binding protein, chitin binding protein, biotin, or
6-histidine tags). Alternatively, approaches other than
radioisotopic labeling can be used to detect the prey
protein. For example, a non-radioactive prey protein,
either isolated from its native context or artificially
generated in an over-expression system, can be used in
the GST-pulldown; once eluted, the prey protein can be
analyzed by SDS-PAGE and quantitative immunoblotting,
or by immunological assay of the total bound fraction
using a microplate formatted assay.
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